STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
P
Completed
- Acute Myeloid Leukemia
- Azacitadine
- +4 more
- Valencia, SpainHospital Universitari i Politècnic La Fe
2020-04-03
Apr 3, 2020U
Completed
- Acute Myeloid Leukemia (AML)
- Cytarabine
- +4 more
- Innsbruck, Austria
- +43 more
2020-12-29
Dec 29, 2020D
Unknown status
- Neutropenia
- lenograstim
- Seoul, Gyounggido, Korea, Republic ofthe Catholic university of Korea
2018-04-07
Apr 7, 2018C
Withdrawn
- Anterior Myocardial Infarction
- Heart Failure
- rhu G-CSF
- +2 more
- Rome, RM, ItalyFondazione Policlinico Universitario Agostino Gemelli
2022-03-28
Mar 28, 2022P
Completed
- Diffuse Large B Cell Lymphoma
- Ofatumumab
- +7 more
- Wrocław, Dolnośląskie, Poland
- +7 more
2021-12-23
Dec 23, 2021C
Completed
- Breast Cancer
- ERIBULIN + G-CSF (Granulocyte-Colony Stimulating Factor)
- Dijon, FranceCGFL
2020-06-23
Jun 23, 2020N
Completed
- Myelodysplastic Syndrome
- +2 more
- Decitabine
- +3 more
- Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
2022-01-30
Jan 30, 2022S
Recruiting
- Pompe Disease
- Los Angeles, CaliforniaSeraph Research Institute
2021-09-30
Sep 30, 2021C
Active, not recruiting
- Cancer, Breast
- +5 more
- Receipt of granulocyte-colony stimulating factor
- (no location specified)
2021-07-24
Jul 24, 2021N
Completed
- HIV Infections
- Los Angeles, California
- +1 more
2021-10-28
Oct 28, 2021C
Not yet recruiting
- Localized Breast Cancer
- Dense dose epirubicin-cyclophosphamide chemotherapy and G-CSF (filgrastim, lenograstim)
- Dense dose epirubicin-cyclophosphamide chemotherapy with administration of peg-G-CSF (pegfilgrastim)
- Dijon, Bourgogne, FranceCentre Georges François Leclerc (CGFL)
2022-03-24
Mar 24, 2022U
Recruiting
- Malignant Melanoma
- Head and Neck Cancer
- Aurora, ColoradoUniversity of Colorado Cancer Center
2022-02-18
Feb 18, 2022S
Recruiting
- Pediatric Cancer
- pegylated recombinant human granulocyte-colony stimulating factor
- Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center,
2021-08-27
Aug 27, 2021S
M
Not yet recruiting
- Healthy
- Filgrastim Megalabs
- Granulokine
- (no location specified)
2021-09-07
Sep 7, 2021C
Suspended
- Repeated Embryo Implantation Failure
- Montreal, Quebec, CanadaClinique Ovo
2021-02-03
Feb 3, 2021A
Completed
- Advanced Solid Tumors
- ARRY-520, KSP(Eg5) inhibitor; intravenous
- Filgrastim, granulocyte-colony stimulating factor (G-CSF); subcutaneous
- Baltimore, Maryland
- +1 more
2020-09-24
Sep 24, 2020M
Completed
- Atherosclerosis, Coronary
- Autologous CD34+ Cells
- Granulocyte Colony-Stimulating Factor (G-CSF)
- Rochester, MinnesotaMayo Clinic in Rochester
2022-02-04
Feb 4, 2022M
Recruiting
- Neuroblastoma
- Thiotepa
- +6 more
- Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
2021-08-13
Aug 13, 2021U
Completed
- Multiple Myeloma, Relapsed
- Multiple Myeloma, Refractory to Standard Treatment
- Total Marrow Irradiation
- +3 more
- Chicago, IllinoisUniversity of Illinois Cancer Center
2021-11-20
Nov 20, 2021W
Completed
- Infertility
- Granulocyte Colony Stimulating Factor
- +2 more
- Maadi, Cairo, EgyptWael El-Banna Clinic
2021-11-27
Nov 27, 2021B
Completed
- Breast Cancer
- Lung Cancer
- filgrastim, TBO-filgrastim or pegfilgrastim
- (no location specified)
2021-07-24
Jul 24, 2021C
Recruiting
- Healthy
- Duarte, California
- +19 more
2022-03-07
Mar 7, 2022U
Terminated
- Myeloid Neoplasm
- +2 more
- Cladribine
- +3 more
- Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
2022-01-05
Jan 5, 2022O
Recruiting
- Early-stage Breast Cancer
- Ottawa, Ontario, CanadaOttawa Hospital Research Institute
2021-06-10
Jun 10, 2021